Stay updated on Pembrolizumab for Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Head and Neck Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error page, replacing the expected study content with an error screen.
    Difference
    23%
    Check dated 2026-09-22T22:08:56.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.7.0 was added to the page's revision history, replacing the previous Revision: v3.6.6. This indicates a new release of the page content or UI since the last update.
    Difference
    0.0%
    Check dated 2026-09-15T20:55:00.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.6.6, replacing v3.6.5, indicating a small page update. This reflects a minor update to the page rather than a substantive content change.
    Difference
    0.0%
    Check dated 2026-09-01T18:40:18.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The 'Other Study ID Numbers' list now includes '2014 ( U.S. NIH Grant/Contract )', linking the trial to NIH funding. This enhances the study's funding provenance within the metadata.
    Difference
    0.0%
    Check dated 2026-08-25T19:51:34.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing Revision: v3.6.4, indicating a small software update applied to this page.
    Difference
    0.0%
    Check dated 2026-08-11T16:49:46.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The Plain Language Summary on the study page has been removed, eliminating the patient-friendly overview of the trial.
    Difference
    0.0%
    Check dated 2026-08-04T12:40:38.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Head and Neck Cancer Clinical Trial page.